Cargando…

Long-term somatic side-effects and morbidity in testicular cancer patients.

In order to evaluate long-term somatic morbidity after treatment for testicular cancer 149 patients with NED greater than or equal to 3 years answered a questionnaire. The patients had been treated with surgery only (32 patients, radiotherapy only (39 patients), cisplatin-based chemotherapy plus sur...

Descripción completa

Detalles Bibliográficos
Autores principales: Aass, N., Kaasa, S., Lund, E., Kaalhus, O., Heier, M. S., Fosså, S. D.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1990
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1971317/
https://www.ncbi.nlm.nih.gov/pubmed/2297486
_version_ 1782134884107550720
author Aass, N.
Kaasa, S.
Lund, E.
Kaalhus, O.
Heier, M. S.
Fosså, S. D.
author_facet Aass, N.
Kaasa, S.
Lund, E.
Kaalhus, O.
Heier, M. S.
Fosså, S. D.
author_sort Aass, N.
collection PubMed
description In order to evaluate long-term somatic morbidity after treatment for testicular cancer 149 patients with NED greater than or equal to 3 years answered a questionnaire. The patients had been treated with surgery only (32 patients, radiotherapy only (39 patients), cisplatin-based chemotherapy plus surgery (46 patients) or chemotherapy plus radiotherapy with or without surgery (32 patients). Raynaud-like phenomena were the most frequent side-effect occurring significantly more often after cisplatin-based chemotherapy than after surgery or radiotherapy (33/72 patients versus 5/68 patients). Peripheral sensory 'neuropathy' was reported by 18% of all the patients. Seventeen per cent and 11% complained of pulmonary symptoms and auditory symptoms, respectively. Gastrointestinal side-effects were more frequent after any type of cytotoxic therapy than after surgery only (34/47 patients versus 5/22 patients). Twenty-six patients had fathered children after treatment. About 80% of the patients were in full time wage-earning activity when they answered the questionnaire. In conclusion, 3-7 years after treatment for testicular cancer, 30-50% of the patients had minor somatic complaints whereas serious side-effects seldom occurred.
format Text
id pubmed-1971317
institution National Center for Biotechnology Information
language English
publishDate 1990
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-19713172009-09-10 Long-term somatic side-effects and morbidity in testicular cancer patients. Aass, N. Kaasa, S. Lund, E. Kaalhus, O. Heier, M. S. Fosså, S. D. Br J Cancer Research Article In order to evaluate long-term somatic morbidity after treatment for testicular cancer 149 patients with NED greater than or equal to 3 years answered a questionnaire. The patients had been treated with surgery only (32 patients, radiotherapy only (39 patients), cisplatin-based chemotherapy plus surgery (46 patients) or chemotherapy plus radiotherapy with or without surgery (32 patients). Raynaud-like phenomena were the most frequent side-effect occurring significantly more often after cisplatin-based chemotherapy than after surgery or radiotherapy (33/72 patients versus 5/68 patients). Peripheral sensory 'neuropathy' was reported by 18% of all the patients. Seventeen per cent and 11% complained of pulmonary symptoms and auditory symptoms, respectively. Gastrointestinal side-effects were more frequent after any type of cytotoxic therapy than after surgery only (34/47 patients versus 5/22 patients). Twenty-six patients had fathered children after treatment. About 80% of the patients were in full time wage-earning activity when they answered the questionnaire. In conclusion, 3-7 years after treatment for testicular cancer, 30-50% of the patients had minor somatic complaints whereas serious side-effects seldom occurred. Nature Publishing Group 1990-01 /pmc/articles/PMC1971317/ /pubmed/2297486 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Research Article
Aass, N.
Kaasa, S.
Lund, E.
Kaalhus, O.
Heier, M. S.
Fosså, S. D.
Long-term somatic side-effects and morbidity in testicular cancer patients.
title Long-term somatic side-effects and morbidity in testicular cancer patients.
title_full Long-term somatic side-effects and morbidity in testicular cancer patients.
title_fullStr Long-term somatic side-effects and morbidity in testicular cancer patients.
title_full_unstemmed Long-term somatic side-effects and morbidity in testicular cancer patients.
title_short Long-term somatic side-effects and morbidity in testicular cancer patients.
title_sort long-term somatic side-effects and morbidity in testicular cancer patients.
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1971317/
https://www.ncbi.nlm.nih.gov/pubmed/2297486
work_keys_str_mv AT aassn longtermsomaticsideeffectsandmorbidityintesticularcancerpatients
AT kaasas longtermsomaticsideeffectsandmorbidityintesticularcancerpatients
AT lunde longtermsomaticsideeffectsandmorbidityintesticularcancerpatients
AT kaalhuso longtermsomaticsideeffectsandmorbidityintesticularcancerpatients
AT heierms longtermsomaticsideeffectsandmorbidityintesticularcancerpatients
AT fossasd longtermsomaticsideeffectsandmorbidityintesticularcancerpatients